Pharmacy Times

JANUARY 26, 2024

Pharmacists can also ensure proper education and selection of therapy before and after discharge.

152

152

STAT

JANUARY 26, 2024

There are more openly LGBTQ+ people in the U.S. than ever, but little is known about the unique health challenges they may face. That’s why some researchers are urging health systems to build the acronym SOGIE — for patients’ sexual orientation and gender identity and expression — into their data collection. In a paper published Wednesday in JAMA Cardiology , a group of cardiologists write that there is an urgent need to begin collecting SOGIE data more systematically

140

140

Pharmacy Times

JANUARY 26, 2024

By offering personalized guidance, promoting awareness, and fostering open communication, pharmacists can empower their patients to navigate the new year with a focus on both wellness and safety.

Communication 149

Communication 149

STAT

JANUARY 26, 2024

When I enter, “what is pediatrics?” into an image search engine, I get back dozens of stock photos with smiling physicians listening to beaming children’s hearts or looking in their ears. I love those images. They reflect the routine joy and trust that encompass many days in the life of a pediatrician. Increasingly, though, the answer to that question doesn’t quite match the happy imagery.

138

138

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

JANUARY 26, 2024

These patients may have a similar genetic susceptibility for type 2 diabetes.

139

139

STAT

JANUARY 26, 2024

WASHINGTON — Merck CEO Robert Davis and Johnson & Johnson CEO Joaquin Duato have agreed to voluntarily testify before the Senate health committee, avoiding a threatened subpoena, the committee announced Friday. The decision by the executives came after a public pressure campaign by Sanders to get the two executives and Bristol Myers Squibb CEO Chris Boerner to testify about why prices for their drugs are higher in the United States than in other countries.

135

135

Fierce Healthcare

JANUARY 26, 2024

As artificial intelligence advances in different areas of healthcare, there are concerns that technology and AI-based chatbots will replace the human connections between patients and practitioners. | A new study finds promising potential for AI and large language models to enhance mental health therapy at scale by being able to analyze millions of text-based counseling messages to shine a light on what works.

134

134

Fierce Pharma

JANUARY 26, 2024

Merck’s unique approval for Keytruda as a postsurgical treatment for resectable kidney cancer has gained new backing in the form of data showing the PD-1 inhibitor can extend patients’ lives. | Merck’s unique approval for Keytruda as a postsurgerical treatment for resectable kidney cancer has gained new backing in the form of data showing the PD-1 inhibitor can extend patients’ lives.

132

132

Pharmacy Times

JANUARY 26, 2024

Jennifer Marsh, PharmD, BCCCP, discusses the current standard of care for hepatic encephalopathy, highlighting challenges in treatment, prescription drug coverage, transition of care, and outpatient treatment access.

132

132

STAT

JANUARY 26, 2024

Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report. Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.

Vaccines 132

Vaccines 132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JANUARY 26, 2024

To turn the tide around on the growing teen mental health crisis, the U.S. | Social media is cited as one of the drivers of the worsening crisis along with COVID-19, gun violence and the threat of climate change.

131

131

STAT

JANUARY 26, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at a biotech rarity, a milestone on Wall Street, and pharma’s latest run-in with Washington.

126

126

Fierce Healthcare

JANUARY 26, 2024

Cognoa, maker of the first FDA-approved autism diagnostic tool, announced Highmark has signed on as its first commercial payer partner. | The tool, Canvas Dx, leverages AI to empower doctors to quickly and accurately diagnose developmental risk without bias, the company claims. It is the first FDA-approved autism diagnostic tool.

FDA 131

FDA 131

Fierce Pharma

JANUARY 26, 2024

The combination of Merck's Keytruda and Pfizer and Astellas' Padcev recently made waves in bladder cancer—and the broader oncology world—by delivering a massive life-extension benefit against | The combination of Merck's Keytruda and Pfizer and Astellas' Padcev recently made waves in bladder cancer—and the broader oncology world—by delivering a massive life-extension benefit.

126

126

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JANUARY 26, 2024

In the age of artificial intelligence, things are moving at warp speed, noted UNC Health CIO Brent Lamm. | “We have been very aggressive over the past 12 to 18 months at UNC Health to seek out any and every opportunity to try to remove or reduce the administrative burden for our provider teams," CIO Brent Lamm said.

128

128

Fierce Pharma

JANUARY 26, 2024

With the unusual threat of a Senate subpoena hanging over their heads, the CEOs of Johnson & Johnson and Merck & Co. | With the unusual threat of a Senate subpoena hanging over their heads, the CEOs of Johnson & Johnson and Merck & Co. have agreed to join their counterpart at Bristol Myers Squibb in testifying before the Senate Committee on Health, Education, Labor and Pensions (HELP).

124

124

Pharmacy Times

JANUARY 26, 2024

Compared to TACE alone, durvalumab plus TACE and bevacizumab reduced the risk of disease progression or death by 23%; however, further research is needed to assess OS.

123

123

Drug Topics

JANUARY 26, 2024

Compared to only 10% of primary and subspecialty visits, 34.5% of mental health visits took place via video in August 2023.

123

123

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JANUARY 26, 2024

The combination resulted in numerically longer OS compared with an NSAI alone.

122

122

Fierce Healthcare

JANUARY 26, 2024

State Medicaid agencies are required to cover Hepatitis C medications for people who have the disease or a substance use disorder, states were "encouraged" earlier this week. | State Medicaid agencies were reminded of their responsibility to offer Hepatitis C medications, or direct-acting antivirals (DAAs), to individuals with substance use disorder.

119

119

Fierce Pharma

JANUARY 26, 2024

At Sanofi and Regeneron, it’s all about the kids—at least with respect to their recent advancements of anti-inflammatory powerhouse Dupixent. | The FDA has signed off on Sanofi and Regeneron's Dupixent to treat children between the ages of 1 and 11 who weigh at least 33 pounds with eosinophilic esophagitis. Dupixent becomes the first treatment in the U.S. for children in this age group with the disorder.

FDA 118

FDA 118

pharmaphorum

JANUARY 26, 2024

JP Morgan 2024 – Frank Gleeson Mike.

116

116

Fierce Pharma

JANUARY 26, 2024

In late 2022, GSK, Sanofi and Takeda signed on with a partnership of local agencies to advance biologic manufacturing in Singapore. | In late 2022, GSK, Sanofi and Takeda signed on with a partnership of local agencies to advance biologic manufacturing in Singapore. Now, a little more than a year later, AbbVie is getting in on the action by starting a major production expansion in the Garden City.

116

116

Pharmaceutical Commerce

JANUARY 26, 2024

Concerns regarding hypoglycemia potentially linked to a counterfeit version of Ozempic come at a time in which reports have grown regarding the improper use of GLP-1 receptor agonists for the purpose of cosmetic weight loss.

115

115

STAT

JANUARY 26, 2024

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We do, however, plan to catch up on our reading, promenade with the official mascots, and hold another listening party with Mrs. Pharmalot. For now, the rotation will likely include this , this , this and this.

115

115

Fierce Pharma

JANUARY 26, 2024

Shortly after Europe’s Committee for Medicinal Products for Human Use (CHMP) recommended refusal of a marketing authorization | Shortly after Europe’s Committee for Medicinal Products for Human Use (CHMP) recommended refusal of marketing authorization for Apellis’ geographic atrophy (GA) drug Syfovre (pegcetacoplan injection), the company said it will appeal the guidance.

115

115

STAT

JANUARY 26, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

113

113

Fierce Healthcare

JANUARY 26, 2024

Blue Shield of California is offering to foot the bill for Medicaid enrollees who want to earn a General Education Diploma and become high school graduates. | The program, being rolled out in Los Angeles and San Diego counties, addresses a trend of fewer people graduating from high school.

113

113

Drug Topics

JANUARY 26, 2024

Smartphone apps were effective at promoting weight loss and reducing BMI, but had no impact on HbA1c levels or waist circumference.

112

112

The Checkup by Singlecare

JANUARY 26, 2024

Ozempic (semaglutide) is one of the most popular prescription drugs for treating Type 2 diabetes on the market. Approved by the Food and Drug Administration (FDA) in 2017 for blood sugar management, Ozempic has recently gained attention for its weight loss effects. Healthcare professionals prescribe Ozempic off-label for weight management for patients with obesity.

Labelling 111

Labelling FDA 111

pharmaphorum

JANUARY 26, 2024

AbbVie has broken ground on a new $223 million expansion of its biologics manufacturing facility in Singapore, creating around 100 new jobs

110

110

Drug Store News

JANUARY 26, 2024

Consumers can expect several launches across the brand's gel couture be-dazzled, expressive and regular polish lines.

110

110

pharmaphorum

JANUARY 26, 2024

Report on UK biotech sector by Tony Blair and William Hague calls for an NHS trust to be set up to oversee and sell patient data

110

110